Inhibitory effects of high glucose/insulin environment on osteoclast formation and resorption in vitro

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 33, Issue 2, 2013, Pages 244-249

  Xu, Fei ^a   Ye, Yaping ^a   Dong, Yonghui ^a   Guo, Fengjing ^a   Chen, Amin ^a   Huang, Shilong ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Glucose; Insulin; Osteoclastogenesis; Type 2 diabetes mellitus

Indexed keywords

GLUCOSE; INSULIN;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; HUMAN; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; BONE RESORPTION; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; INSULIN; MICE; MICE, INBRED C57BL; OSTEOCLASTS;

EID: 84899102342     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-013-1105-z     Document Type: Article

References (21)

1. Rosen P, Nawroth PP, King G, et al. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev, 2001, 17(3):189-212
2. Yaturu S. Diabetes and skeletal health. J Diabetes, 2009, 1(4):246-254
3. Vestergaard P. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes-A meta-Analysis. Osteoporos Int, 2007, 18(4):427-444
4. Hamann C, Goettsch C, Mettelsiefen J, et al. Delayed bone regeneration and low bone mass in a rat model of insulin-resistant type 2 diabetes mellitus is due to impaired osteoblast function. Am J Physiol Endocrinol Metab, 2011, 301(6):E1220-1228
5. Okazaki R, Miura M, Toriumi M, et al. Short-term treatment with troglitazone decreases bone turnover in patients with type 2 diabetes mellitus. Endocr J, 1999, 46(6):795-801
6. Shockley KR, Lazarenko OP, Czernik PJ, et al. PPARgamma2 nuclear receptor controls multiple regulatory pathways of osteoblast differentiation from marrow mesenchymal stem cells. J Cell Biochem, 2009, 106(2): 232-246
7. Hie M, Iitsuka N, Otsuka T, et al. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation. Int J Mol Med, 2011, 28(3): 455-462
8. Nakasato YR, Janckila AJ, Halleen JM, et al. Clinical significance of immunoassays for type-5 tartrate-resistant acid phosphatase. Clin Chem, 1999, 45(12):2150-2157
9. Yang L, Perez-Amodio S, Barrere-de Groot FY, et al. The effects of inorganic additives to calcium phosphate on in vitro behavior of osteoblasts and osteoclasts. Biomaterials, 2010, 31(11):2976-2989
10. Janghorbani M, Van Dam RM, Willett WC, et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. Am J Epidemiol, 2007, 166(5):495-505
11. Li Z, Kong K, Qi W. Osteoclast and its roles in calcium metabolism and bone development and remodeling. Biochem Biophys Res Commun, 2006, 343(2):345-350
12. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest, 2005, 115(12):3318-3325
13. Boyle WJ, Simonet WS, Lacey DL. Osteoclast differentiation and activation. Nature, 2003, 423(6937):337-342
14. Rauner M, Sipos W, Pietschmann P. Osteoimmunology. Int Arch Allergy Immunol, 2007, 143(1):31-48
15. Sipos W, Pietschmann P, Rauner M, et al. Pathophysiology of osteoporosis. Wien Med Wochenschr, 2009, 159 (9-10):230-234
16. Gopalakrishnan V, Vignesh RC, Arunakaran J, et al. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages. Biochem Cell Biol, 2006, 84(1):93-101
17. Zhen D, Chen Y, Tang X. Metformin reverses the deleterious effects of high glucose on osteoblast function. J Diabetes Complications, 2010, 24(5):334-344
18. Freude T, Braun KF, Haug A, et al. Hyperinsulinemia reduces osteoblast activity in vitro via upregulation of TGF-beta. J Mol Med (Berl), 2012, 90(11):1257-1266
19. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell, 2010, 142(2):296-308
20. Wittrant Y, Gorin Y, Woodruff K, et al. High d(+)glucose concentration inhibits RANKL-induced osteoclastogenesis. Bone, 2008, 42(6):1122-1130
21. Huang S, Kaw M, Harris MT, et al. Decreased osteoclastogenesis and high bone mass in mice with impaired insulin clearance due to liver-specific inactivation to CEACAM1. Bone, 2010, 46(4):1138-1145